(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion ...

Trump is targeting China's transshipments through Southeast Asia. But can tariffs and trade agreements really curb China's ...

Though the Trump administration and European Union have agreed to a deal that reduces planned U.S. tariffs, Mexico still ...

The 15% tariff would be lower than previously threatened, but it would remain a high duty on America’s largest trading ...

Cipla's CEO addresses impact of US tariffs on pharmaceutical industry, remains optimistic about company's performance and ...

US tariffs have had a serious adverse effect on overall South Korean exports, an examination of data indicates. Goods subject to sectoral tariffs showed notable declines. In addition, the heavy ...

The announcement and anticipation of US tariffs have already had an immediate and devastating impact on trade performance.

The construction market in the United States is expected to be the most impacted by tariff policies and will slow throughout ...

US President Donald Trump announced on Sunday that the United States was imposing 15-percent tariffs on all European Union countries.

The economic landscape for companies operating in the United States is showing the first signs of strain from tariffs imposed by the Trump administration.

When President Donald Trump announced 10% global tariffs in April, the pharma industry remained largely unscathed. However, the president has since threatened to slap additional tariffs on ...

Toy companies have been fretting about the impact of Trump's global tariff blitz on the industry, particularly when it comes ...